Qube Research & Technologies (QRT) Portfolio holdings
AUM $72B
1-Year Return
7.86%
This Quarter Return
-0.96%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$54.2B
AUM Growth
-$1.16B
(-2.1%)
Cap. Flow
-$432M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
16.28%
Holding
4,400
New
506
Increased
1,215
Reduced
1,314
Closed
1,050
Top Buys
| 1 |
Broadcom
AVGO
|
+$643M |
| 2 |
Accenture
ACN
|
+$430M |
| 3 |
Merck
MRK
|
+$363M |
| 4 |
Lam Research
LRCX
|
+$324M |
| 5 |
Northrop Grumman
NOC
|
+$323M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Zoetis
ZTS
|
+$359M |
| 3 |
UnitedHealth
UNH
|
+$347M |
| 4 |
McDonald's
MCD
|
+$330M |
| 5 |
Honeywell
HON
|
+$292M |
Sector Composition
| 1 | Technology | 20.91% |
| 2 | Industrials | 13.11% |
| 3 | Financials | 11.91% |
| 4 | Healthcare | 11.89% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
iShares S&P GSCI Commodity-Indexed Trust
GSG
$978M
| $71.3K | ﹤0.01% |
3,219
-10,952
| -77% | -$243K |
|
2302
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$8.04B
| $70.7K | ﹤0.01% |
1,707
-52,843
| -97% | -$2.19M |
|
2303
Greif Class B
GEF.B
$2.46B
| $70.3K | ﹤0.01% |
1,125
-1,319
| -54% | -$82.4K |
|
2304
LINKBANCORP
LNKB
$275M
| $69.9K | ﹤0.01% |
11,428
-60,603
| -84% | -$371K |
|
2305
AngioDynamics
ANGO
$447M
| $69.2K | ﹤0.01% |
11,442
-132,557
| -92% | -$802K |
|
2306
American Well
AMWL
$106M
| $69.2K | ﹤0.01% |
10,656
-2,591
| -20% | -$16.8K |
|
2307
Capricor Therapeutics
CAPR
$293M
| $68.8K | ﹤0.01% |
14,433
-54,970
| -79% | -$262K |
|
2308
Vanguard S&P 500 Value ETF
VOOV
$5.67B
| $68.4K | ﹤0.01% |
389
-79
| -17% | -$13.9K |
|
2309
C3.ai
AI
$2.48B
| $68.4K | ﹤0.01% |
2,361
-5,181
| -69% | -$150K |
|
2310
Lineage Cell Therapeutics
LCTX
$354M
| $68.1K | ﹤0.01% |
68,286
+55,163
| +420% | +$55K |
|
2311
Gold Royalty Corp
GROY
$618M
| $68.1K | ﹤0.01% |
+48,271
| New | +$68.1K |
|
2312
AGNC Investment
AGNC
$10.6B
| $67.9K | ﹤0.01% |
+7,117
| New | +$67.9K |
|
2313
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$13B
| $67.4K | ﹤0.01% |
1,624
+325
| +25% | +$13.5K |
|
2314
Neuropace
NPCE
$341M
| $66.8K | ﹤0.01% |
8,833
-36,385
| -80% | -$275K |
|
2315
CytomX Therapeutics
CTMX
$336M
| $66.6K | ﹤0.01% |
54,608
-78,591
| -59% | -$95.9K |
|
2316
XBiotech
XBIT
$84.1M
| $66.4K | ﹤0.01% |
12,917
-54,745
| -81% | -$281K |
|
2317
iShares Global 100 ETF
IOO
$7.23B
| $66.4K | ﹤0.01% |
687
-9,445
| -93% | -$912K |
|
2318
Capital Group Dividend Value ETF
CGDV
$22B
| $66.2K | ﹤0.01% |
2,005
-68,615
| -97% | -$2.26M |
|
2319
Noodles & Co
NDLS
$31.1M
| $65.4K | ﹤0.01% |
+41,412
| New | +$65.4K |
|
2320
Zillow
Z
$21.8B
| $65K | ﹤0.01% |
1,402
-245,010
| -99% | -$11.4M |
|
2321
Camden National
CAC
$703M
| $64.8K | ﹤0.01% |
1,964
+1,514
| +336% | +$50K |
|
|
GPMT
2322
Granite Point Mortgage Trust
GPMT
$147M
| $64.7K | ﹤0.01% |
21,795
+13,985
| +179% | +$41.5K |
|
2323
LCI Industries
LCII
$2.4B
| $64.5K | ﹤0.01% |
624
-2,852
| -82% | -$295K |
|
|
QIPT
2324
Quipt Home Medical
QIPT
$119M
| $64.3K | ﹤0.01% |
19,961
-25,520
| -56% | -$82.2K |
|
2325
BNY Mellon US Large Cap Core Equity ETF
BKLC
$4.28B
| $63.9K | ﹤0.01% |
616
+558
| +962% | +$57.9K |
|